Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Beier Bioengineering is a China-based in vitro diagnostics company focused on the research, development, manufacturing, and commercialization of diagnostic reagents and supporting instruments. Founded in 1995 in Beijing, the company markets a broad menu of IVD products covering infectious disease, tumor marker, fertility, cardiac marker, and hormone testing. Its technology base includes ELISA, rapid lateral-flow or colloidal gold tests, chemiluminescence immunoassays, biochemical diagnostics, and molecular diagnostic platforms, and it also reports development of automated chemiluminescence analyzers. The business appears to be a commercial-stage diagnostics manufacturer rather than a therapeutics developer, with GMP- and ISO 13485-aligned quality systems and domestic as well as export-oriented operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Beier Bioengineering.